RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
69 hedge funds and large institutions have $438M invested in Ra Pharmaceuticals, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 62 → 69 (+7)
Holders
69
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.27M | |
| 2 | +$6.31M | |
| 3 | +$5.36M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$5.16M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$3.78M |
Top Sellers
| 1 | -$22.4M | |
| 2 | -$3.04M | |
| 3 | -$2.19M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$785K |
| 5 |
Goldman Sachs
New York
|
-$755K |